Cargando…

Advances in Gene Therapy for Diseases of the Eye

Over the last few years, huge progress has been made with regard to the understanding of molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the eye. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Challenges re...

Descripción completa

Detalles Bibliográficos
Autores principales: Petit, Lolita, Khanna, Hemant, Punzo, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991575/
https://www.ncbi.nlm.nih.gov/pubmed/27178388
http://dx.doi.org/10.1089/hum.2016.040
_version_ 1782448879857303552
author Petit, Lolita
Khanna, Hemant
Punzo, Claudio
author_facet Petit, Lolita
Khanna, Hemant
Punzo, Claudio
author_sort Petit, Lolita
collection PubMed
description Over the last few years, huge progress has been made with regard to the understanding of molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the eye. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Challenges regarding the efficacy and efficiency of therapeutic gene delivery have driven the development of novel therapeutic approaches, which continue to evolve the field of ocular gene therapy. In this review article, we will discuss the evolution of preclinical and clinical strategies that have improved gene therapy in the eye, showing that treatment of vision loss has a bright future.
format Online
Article
Text
id pubmed-4991575
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-49915752016-09-06 Advances in Gene Therapy for Diseases of the Eye Petit, Lolita Khanna, Hemant Punzo, Claudio Hum Gene Ther Review Over the last few years, huge progress has been made with regard to the understanding of molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the eye. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Challenges regarding the efficacy and efficiency of therapeutic gene delivery have driven the development of novel therapeutic approaches, which continue to evolve the field of ocular gene therapy. In this review article, we will discuss the evolution of preclinical and clinical strategies that have improved gene therapy in the eye, showing that treatment of vision loss has a bright future. Mary Ann Liebert, Inc. 2016-08-01 2016-08-01 /pmc/articles/PMC4991575/ /pubmed/27178388 http://dx.doi.org/10.1089/hum.2016.040 Text en © Lolita Petit et al., 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review
Petit, Lolita
Khanna, Hemant
Punzo, Claudio
Advances in Gene Therapy for Diseases of the Eye
title Advances in Gene Therapy for Diseases of the Eye
title_full Advances in Gene Therapy for Diseases of the Eye
title_fullStr Advances in Gene Therapy for Diseases of the Eye
title_full_unstemmed Advances in Gene Therapy for Diseases of the Eye
title_short Advances in Gene Therapy for Diseases of the Eye
title_sort advances in gene therapy for diseases of the eye
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991575/
https://www.ncbi.nlm.nih.gov/pubmed/27178388
http://dx.doi.org/10.1089/hum.2016.040
work_keys_str_mv AT petitlolita advancesingenetherapyfordiseasesoftheeye
AT khannahemant advancesingenetherapyfordiseasesoftheeye
AT punzoclaudio advancesingenetherapyfordiseasesoftheeye